Open Access Open Access  Restricted Access Subscription or Fee Access

Clinical Evaluation of Mycobacterium Tuberculosis Culture and Multiplex PCR for the Characterization of Multiple Drug Resistance Tuberculosis in Dehradun, Uttarakhand, India

Aditi Sharma, Narotam Sharma


Multiple drug resistance (MDR) tuberculosis timely diagnose is of utmost clinical relevance and needs to be diagnose at initial stages for the proper treatment. The current study was done to detect the multiple genes for MDR tuberculosis (TB) in clinical isolates by molecular tools. 186 clinical samples were considered out and subjected for AFB smear preparation, Nested PCR (IS6110) for Mycobacterium tuberculosis complex detection and MDR TB PCR targeting rpoB, kat G, mab A promoter. Twenty-six came positive for AFB smears, out of which 08 were pulmonary and 04 were extra pulmonary. Nested PCR targeting IS6110 gene was amplified at 123 base pairs with 340 base pairs as IC (internal control) was seen in 43 cases which include 38 extra pulmonary. The Positive TB PCR specimens were subjected for MDRTB PCR Only 05 cases yielded, an amplicon of 315 bp confirming the rpoB gene resistance for resistance for rifampcin drug. In any of the 05 positives none of the other resistance gene other than rpoB was amplified. Targeting IS6110 gene and rpoB genes at once, additional information will be gained from a single test run that otherwise would require several times the reagents and more time to perform. Current study signifies the usage of quick, cost effective, DNA sequences based method for MULTIPLEX OF MDR TB detection where disease will be diagnosed earlier and hence treatment would be started at an early stage. Such experimental studies will be useful to prepare strategies for the management of the disease and to formulate the plans in Revised National Tuberculosis Control Program (RNTCP) in India as well as it will help in managing the global tuberculosis burden. The ease to execute the standardized protocols and methodologies to study the slow grower clinically relevant pathogens like M. tuberculosis.

Full Text:



D.H. Kennedy, R.J. Fallon. Tuberculosis meningitis, JAMA. 1979; 241: 264–8p.

V. Ramalingaswami. Opening address, In: Drug Resistance: Mechanism and Management, Proceedings of the Fourth Annual Ranbaxy Science Foundation Symposium. R.L. Singhal, O.P. Sood (Eds.), New Delhi, India: Communicore Publishers; 1998, 1–3p.

N. Sharma, V. Sharma, P.R. Singh, B. Jawed, V. Babu, J. Kandpal, S.C. Nautiyal, R.K. Singh. Tuberculosis and molecular diagnosis, Webmed – Central Biotechnol. 2013; 4: WMC003992.

M. Morgan, S. Kalantri, L. Flores, M. Pai. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis, BMC Infect Dis. 2005; 5: 62p.

T. Friend. The Third Domain. National Academies Press; 2007.

S. Das, C.N. Paramasivan, D.B. Lowrie, R. Prabhakar, P.R. Narayanan. IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India, Tubercle Lung Dis. 1995; 76(6): 550–4p.

J.S. Bergmann, G. Yuoh, G. Fish, G.L. Woods. Clinical evaluation of the enhanced Gen-Probe amplified Mycobacterium tuberculosis direct test for rapid diagnosis of tuberculosis in prison inmates, J Clin Microbiol. 1999; 37: 1419–25p.

A. Pooran, E. Pieterson, M. Davids, G. Theron, K. Dheda. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS One. 2013; 8: e54587.

G.E. Thwaites, T.T. Chau, J.J. Farrar. Improving the bacteriological diagnosis of tuberculous meningitis, J Clin Microbiol. 2004; 42: 378–9p.

S.M. Wilson, R. McNerney, P.M. Nye, G. Godfrey-Faussett, N.G. Stoker, A. Voller. Progress towards a simplified polymerase chain reaction and its application to diagnosis of tuberculosis, J Clin Microbiol. 1993; 31: 776–82p.



  • There are currently no refbacks.